Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,475 | 181 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,191 | 102 | $0 (2023) |
| PFIZER INC. | $239.48 | 14 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $194.36 | 7 | $0 (2021) |
| Lilly USA, LLC | $155.72 | 9 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $125.66 | 11 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $89.95 | 7 | $0 (2019) |
| ABBVIE INC. | $89.88 | 6 | $0 (2023) |
| Dexcom, Inc. | $68.28 | 4 | $0 (2024) |
| Abbott Laboratories | $58.88 | 3 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $49.69 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $109.45 | 6 | Abbott Laboratories ($58.88) |
| 2023 | $189.26 | 12 | Dexcom, Inc. ($50.58) |
| 2022 | $69.46 | 4 | Lilly USA, LLC ($42.42) |
| 2021 | $318.75 | 28 | Novo Nordisk Inc ($125.35) |
| 2020 | $346.03 | 28 | Novo Nordisk Inc ($234.30) |
| 2019 | $421.77 | 20 | Novo Nordisk Inc ($235.44) |
| 2018 | $504.02 | 43 | Novo Nordisk Inc ($330.59) |
| 2017 | $516.25 | 40 | Novo Nordisk Inc ($238.47) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Endocrinology | ||||||
| 09/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Diabetes Care | ||||||
| 08/28/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Diabetes Care | ||||||
| 05/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes Care | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Gastroenterology | ||||||
| 12/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Diabetes | ||||||
| 11/13/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Endocrinology | ||||||
| 09/25/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 09/11/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: INSOMNIA | ||||||
| 08/21/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Endocrinology | ||||||
| 08/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Oncology | ||||||
| 06/06/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: VACCINES | ||||||
| 05/22/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Endocrinology | ||||||
| 05/08/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 01/23/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 06/28/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Diabetes | ||||||
| 05/23/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Diabetes | ||||||
| 01/12/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 10/19/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 226 | 480 | $24,318 | $3,491 |
| 2022 | 31 | 2,763 | 4,127 | $146,755 | $59,285 |
| 2021 | 33 | 4,328 | 6,918 | $223,672 | $84,573 |
| 2020 | 32 | 2,526 | 4,356 | $181,623 | $70,495 |
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 62 | 150 | $12,750 | $1,451 | 11.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Facility | 2023 | 12 | 16 | $2,240 | $511.04 | 22.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2023 | 12 | 12 | $2,196 | $485.16 | 22.1% |
| J2010 | Injection, lincomycin hcl, up to 300 mg | Office | 2023 | 35 | 57 | $1,995 | $397.38 | 19.9% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 37 | 56 | $2,240 | $277.37 | 12.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 24 | 26 | $1,248 | $239.77 | 19.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 144 | $1,440 | $91.56 | 6.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 17 | 19 | $209.00 | $38.12 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 276 | 600 | $54,379 | $32,666 | 60.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 226 | 226 | $3,390 | $3,406 | 100.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 100 | 283 | $15,480 | $2,729 | 17.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 40 | 40 | $3,057 | $2,726 | 89.2% |
| J2010 | Injection, lincomycin hcl, up to 300 mg | Office | 2022 | 75 | 382 | $6,112 | $2,540 | 41.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 134 | 154 | $8,470 | $2,040 | 24.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 42 | $1,680 | $1,194 | 71.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 13 | $2,060 | $1,134 | 55.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 212 | 305 | $1,525 | $901.83 | 59.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 67 | 93 | $2,670 | $892.31 | 33.4% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2022 | 98 | 109 | $3,052 | $776.54 | 25.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 65 | 68 | $3,740 | $709.95 | 19.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 26 | $1,430 | $692.32 | 48.4% |
| 84460 | Liver enzyme (sgpt), level | Office | 2022 | 104 | 119 | $2,856 | $624.01 | 21.8% |
| 84075 | Phosphatase (enzyme) level, alkaline | Office | 2022 | 104 | 119 | $3,808 | $610.07 | 16.0% |
| 84450 | Liver enzyme (sgot), level | Office | 2022 | 104 | 119 | $2,856 | $610.07 | 21.4% |
| 82310 | Calcium level, total | Office | 2022 | 104 | 119 | $2,618 | $607.69 | 23.2% |
About Dr. Paul Meriwether, M.D
Dr. Paul Meriwether, M.D is a Family Medicine healthcare provider based in Mount Pleasant, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093796658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Meriwether, M.D has received a total of $2,475 in payments from pharmaceutical and medical device companies, with $109.45 received in 2024. These payments were reported across 181 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,475).
As a Medicare-enrolled provider, Meriwether has provided services to 9,843 Medicare beneficiaries, totaling 15,881 services with total Medicare billing of $217,845. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mount Pleasant, TX
- Active Since 11/10/2005
- Last Updated 11/11/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093796658
Products in Payments
- Ozempic (Drug) $640.11
- Victoza (Drug) $221.12
- Tresiba (Drug) $164.77
- INVOKANA (Drug) $129.33
- TRULICITY (Drug) $110.24
- FARXIGA (Drug) $89.95
- EUCRISA (Drug) $80.63
- RYBELSUS (Drug) $79.61
- VIAGRA (Drug) $69.79
- Dexcom G6 Transmitter (Medical Supply) $68.28
- XARELTO (Drug) $65.03
- FREESTYLE LIBRE 3 (Device) $58.88
- SOLIQUA (Drug) $55.27
- XIFAXAN (Drug) $54.89
- TOUJEO (Drug) $47.21
- CHANTIX (Drug) $40.07
- Repatha (Biological) $32.64
- QULIPTA (Drug) $29.07
- UBRELVY (Drug) $28.75
- COLOGUARD DNA CAPTURE REAGENTS (Device) $27.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mount Pleasant
Robert Lambert, Md, MD
Family Medicine — Payments: $29,354
Donato Borrillo, M.d, M.D
Family Medicine — Payments: $13,183
Dr. Jeffrey Yonce, Md, MD
Family Medicine — Payments: $10,514
Alaina Payne, Md, MD
Family Medicine — Payments: $9,238
Vinitha Nareddy, M.d, M.D
Family Medicine — Payments: $9,026
Annu Mohan, M.d, M.D
Family Medicine — Payments: $8,226